Meredith Hoog

Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison

Karan Vadher, Hiren Patel, Reema Mody et al. · Diabetes Obesity and Metabolism · 2022 · 55 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long‐term cost‐effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the <scp>United States</scp>

William J. Valentine, Meredith Hoog, Reema Mody et al. · Diabetes Obesity and Metabolism · 2023 · 24 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

The Health Care Resource Utilization and Costs Among Patients With Type 2 Diabetes and Either Cardiovascular Disease or Cardiovascular Risk Factors An Analysis of a US Health Insurance Database

Juliana Meyers, Meredith Hoog, Reema Mody et al. · Clinical Therapeutics · 2021 · 16 citations · Full text

Business, Insurance, Health Assessment +15